ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 479,40
-0,68%
Dow Jones
39 118,86
-0,12%
DAX
18 235,45
0,17%
Brent Oil
84,895
0,05%
Bitcoin
62 770,01
3,09%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Insmed Inc (INSM)

  7. Insmed Inc (INSM) Actualités

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
27/06/202414h00PR Newswire (US)Insmed Announces Redemption of all $225 Million of Outstanding 1.75% Convertible Senior Notes Due 2025NASDAQ:INSMInsmed Inc
13/06/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INSMInsmed Inc
12/06/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INSMInsmed Inc
07/06/202414h00PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
05/06/202414h00PR Newswire (US)Insmed To Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
03/06/202422h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:INSMInsmed Inc
30/05/202422h05PR Newswire (US)Insmed to Host Commercial Webinar on June 4, 2024NASDAQ:INSMInsmed Inc
30/05/202422h02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INSMInsmed Inc
30/05/202414h00PR Newswire (US)Insmed Announces Pricing of $650 Million Public Offering of Common StockNASDAQ:INSMInsmed Inc
29/05/202400h21PR Newswire (US)Insmed Announces Proposed $500 Million Public Offering of Common StockNASDAQ:INSMInsmed Inc
28/05/202412h30PR Newswire (US)Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
27/05/202422h00PR Newswire (US)Insmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with BronchiectasisNASDAQ:INSMInsmed Inc
20/05/202422h28PR Newswire (US)Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International ConfeNASDAQ:INSMInsmed Inc
14/05/202422h06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INSMInsmed Inc
09/05/202413h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INSMInsmed Inc
09/05/202413h00PR Newswire (US)Insmed Reports First-Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
07/05/202414h00PR Newswire (US)Insmed To Present at the BofA Securities Health Care Conference 2024NASDAQ:INSMInsmed Inc
25/04/202414h00PR Newswire (US)Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024NASDAQ:INSMInsmed Inc
27/03/202421h05PR Newswire (US)Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International ConferenceNASDAQ:INSMInsmed Inc
29/02/202414h00PR Newswire (US)Insmed To Present at Three March ConferencesNASDAQ:INSMInsmed Inc
28/02/202422h05PR Newswire (US)Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their HealthNASDAQ:INSMInsmed Inc
22/02/202413h00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INSMInsmed Inc
22/02/202413h00PR Newswire (US)Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
16/02/202423h43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INSMInsmed Inc
14/02/202416h04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:INSMInsmed Inc
08/02/202414h00PR Newswire (US)Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024NASDAQ:INSMInsmed Inc
05/01/202414h00PR Newswire (US)Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
02/01/202414h00PR Newswire (US)Insmed To Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:INSMInsmed Inc
29/11/202314h00PR Newswire (US)Insmed To Present at the Nasdaq 49th Investor ConferenceNASDAQ:INSMInsmed Inc
08/11/202314h00PR Newswire (US)Insmed To Present at Two November ConferencesNASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM

Dernières Valeurs Consultées

EU
SGO
Cie de SaintGobain
EU
EN
Bouygues
NYSE
MRK
Merck
COIN
ETHUSD
Ethereum
EU
VIV
Vivendi
EU
HO
Thales
EU
ORA
Orange
SPI
SP500
S&P 500
NYSE
NKE
Nike
EU
MC
Lvmh Moet Hennessy Louis...
EU
RNO
Renault
EU
PX1
CAC 40
EU
CAP
Capgemini
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés